Compare CBUS & OFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CBUS | OFS |
|---|---|---|
| Founded | 2010 | 2001 |
| Country | United States | United States |
| Employees | N/A | 53 |
| Industry | Agricultural Chemicals | Finance/Investors Services |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 197.5M | 57.2M |
| IPO Year | 2017 | N/A |
| Metric | CBUS | OFS |
|---|---|---|
| Price | $3.35 | $4.04 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $20.00 | N/A |
| AVG Volume (30 Days) | ★ 539.1K | 81.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 17.00% |
| EPS Growth | ★ 58.27 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,262,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $99.13 | N/A |
| P/E Ratio | ★ N/A | $17.44 |
| Revenue Growth | ★ 134.56 | N/A |
| 52 Week Low | $1.09 | $3.98 |
| 52 Week High | $3.80 | $9.80 |
| Indicator | CBUS | OFS |
|---|---|---|
| Relative Strength Index (RSI) | 62.37 | 39.24 |
| Support Level | $1.34 | N/A |
| Resistance Level | N/A | $5.33 |
| Average True Range (ATR) | 0.37 | 0.19 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 76.69 | 10.87 |
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
OFS Capital Corp is an externally managed, closed-end, non-diversified management investment company. Its business objective is to generate current income and capital appreciation by investing in middle-market companies in the United States. The company focuses on investments in senior secured loans, including first lien, second lien, and unitranche loans, as well as subordinated loans and, to a lesser extent, warrants, and other equity securities.